|
ZFP36L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.338800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.170430E-01 |
| Normal-vs-Stage2 |
2.077800E-01 |
| Normal-vs-Stage3 |
6.148200E-01 |
| Normal-vs-Stage4 |
5.450600E-01 |
| Stage1-vs-Stage2 |
8.656400E-01 |
| Stage1-vs-Stage3 |
1.889410E-01 |
| Stage1-vs-Stage4 |
2.717200E-01 |
| Stage2-vs-Stage3 |
2.080600E-01 |
| Stage2-vs-Stage4 |
2.633600E-01 |
| Stage3-vs-Stage4 |
8.059600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.149800E-01 |
| Normal-vs-AfricanAmerican |
7.050800E-01 |
| Normal-vs-Asian |
2.114200E-01 |
| Caucasian-vs-AfricanAmerican |
7.590800E-01 |
| Caucasian-vs-Asian |
5.858400E-01 |
| AfricanAmerican-vs-Asian |
4.805200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.128000E-02 |
| Normal-vs-Female |
1.577240E-01 |
| Male-vs-Female |
2.340100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.707200E-01 |
| Normal-vs-Extreme_Weight |
1.771360E-01 |
| Normal-vs-Obese |
6.826600E-01 |
| Normal-vs-Extreme_Obese |
1.145980E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.815800E-01 |
| Normal_Weight-vs-Obese |
2.561000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.600800E-01 |
| Extreme_Weight-vs-Obese |
1.527980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.919400E-01 |
| Obese-vs-Extreme_Obese |
1.134030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.203000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.033800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.676840E-01 |
| Normal-vs-Age(81-100Yrs) |
1.954850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.968400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.115600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.186000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.153400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.596600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.816000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.490800E-01 |
| Normal-VS-Type2 PRCC |
1.319790E-01 |
| Normal-VS-KIRP CIMP |
2.968100E-02 |
| Normal-VS-Unclassified PRCC |
8.622000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.940800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.809780E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.564800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.702300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.393000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.881600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.044100E-02 |
| Normal-vs-N1 |
1.345150E-01 |
| Normal-vs-N2 |
1.086040E-01 |
| N0-vs-N1 |
2.028400E-02 |
| N0-vs-N2 |
1.024020E-02 |
| N1-vs-N2 |
9.872600E-01 |
|
|
